Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07224087 · ClinicalTrials.gov registry record · Phase 1

Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

A Phase 1 study of Obesity and Smoking Cessation, sponsored by Yale University.

Recruiting
Registry status
Phase 1
Development phase
20
Enrollment target
1
Study location

NCT07224087 is a Phase 1 study of Obesity and Smoking Cessation that is actively recruiting participants, run by Yale University. The registered enrollment target is 20 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07224087, a Phase 1 study of Obesity and Smoking Cessation, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to develop and pilot a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery.

Conditions Studied

Obesity Smoking Cessation Bariatric Surgery Patients

Interventions

  • DRUG Naltrexone Hydrochloride
  • DRUG Bupropion HCl Extended Release
  • BEHAVIORAL Cognitive-Behavioral Therapy

Study Locations (1)

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-03-02
Est. Completion 2027-12-31
Phase Phase 1

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07224087

The ClinicalTrials.gov registry entry for NCT07224087 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Naltrexone Hydrochloride is the first listed.

NCT07224087 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT07224087 about?

NCT07224087 is a clinical study titled "Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients". The purpose of this research study is to develop and pilot a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery.

What is the current status of trial NCT07224087?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2026-03-02. Estimated completion is 2027-12-31.

What conditions does trial NCT07224087 study?

This clinical trial studies the following conditions: Obesity, Smoking Cessation, Bariatric Surgery Patients.

What interventions are being tested in trial NCT07224087?

The interventions under investigation include: Naltrexone Hydrochloride (DRUG), Bupropion HCl Extended Release (DRUG), Cognitive-Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT07224087?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07224087 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

Smoking Cessation

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.